Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SLC29A2 | Human | (S)-amphetamine | increases expression | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | Dextroamphetamine results in increased expression of SLC29A2 mRNA | CTD | PMID:16715494 | SLC29A2 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC29A2 mRNA | CTD | PMID:30165855 | SLC29A2 | Human | 2'-deoxyadenosine | multiple interactions | ISO | Slc29a2 (Mus musculus) | 6480464 | 2'-deoxyadenosine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine] | CTD | PMID:11085929 | SLC29A2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc29a2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC29A2 mRNA | CTD | PMID:18343893 and PMID:21570461 | SLC29A2 | Human | 2,3,7,8-Tetrachlorodibenzofuran | affects expression | ISO | Slc29a2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:18343893 | SLC29A2 | Human | 3-Iodothyronamine | affects uptake | EXP | | 6480464 | SLC29A2 mRNA affects the uptake of 3-iodothyronamine | CTD | PMID:19074582 | SLC29A2 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of SLC29A2 mRNA | CTD | PMID:27685785 | SLC29A2 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Slc29a2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of SLC29A2 gene | CTD | PMID:31683443 | SLC29A2 | Human | 5-aza-2'-deoxycytidine | decreases expression | EXP | | 6480464 | Decitabine results in decreased expression of SLC29A2 mRNA | CTD | PMID:19194470 | SLC29A2 | Human | 5-azacytidine | decreases expression | EXP | | 6480464 | Azacitidine results in decreased expression of SLC29A2 mRNA | CTD | PMID:19194470 | SLC29A2 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SLC29A2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SLC29A2 mRNA | CTD | PMID:32699268 | SLC29A2 | Human | adenine | multiple interactions | ISO | Slc29a2 (Mus musculus) | 6480464 | Adenine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine] | CTD | PMID:11085929 | SLC29A2 | Human | adenosine | increases uptake | EXP | | 6480464 | SLC29A2 protein results in increased uptake of Adenosine | CTD | PMID:9396714 | SLC29A2 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SLC29A2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SLC29A2 mRNA | CTD | PMID:32699268 | SLC29A2 | Human | ammonium chloride | affects expression | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of SLC29A2 mRNA | CTD | PMID:16483693 | SLC29A2 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of SLC29A2 gene | CTD | PMID:25304211 | SLC29A2 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of SLC29A2 gene | CTD | PMID:25304211 | SLC29A2 | Human | bisphenol A | decreases expression | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SLC29A2 mRNA | CTD | PMID:25181051 | SLC29A2 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC29A2 mRNA | CTD | PMID:27685785 | SLC29A2 | Human | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of SLC29A2 mRNA | CTD | PMID:24376830 | SLC29A2 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of SLC29A2 mRNA | CTD | PMID:27594783 | SLC29A2 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of SLC29A2 mRNA | CTD | PMID:27392435 | SLC29A2 | Human | cocaine | decreases expression | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | Cocaine results in decreased expression of SLC29A2 mRNA | CTD | PMID:17898221 | SLC29A2 | Human | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLC29A2 mRNA | CTD | PMID:20971185 | SLC29A2 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLC29A2 mRNA | CTD | PMID:20971185 | SLC29A2 | Human | cytidine | multiple interactions | ISO | Slc29a2 (Mus musculus) | 6480464 | Cytidine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine] | CTD | PMID:11085929 | SLC29A2 | Human | dextran sulfate | multiple interactions | ISO | Slc29a2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC29A2 mRNA | CTD | PMID:29950665 | SLC29A2 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of SLC29A2 mRNA | CTD | PMID:28302478 | SLC29A2 | Human | dipyridamole | multiple interactions | EXP | | 6480464 | Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]] | CTD | PMID:10366666 | SLC29A2 | Human | dipyridamole | multiple interactions | ISO | Slc29a2 (Mus musculus) | 6480464 | Dipyridamole inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine] | CTD | PMID:11085929 | SLC29A2 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SLC29A2 mRNA | CTD | PMID:29803840 | SLC29A2 | Human | endosulfan | increases expression | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of SLC29A2 mRNA | CTD | PMID:29391264 | SLC29A2 | Human | ethanol | increases expression | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | Ethanol results in increased expression of SLC29A2 mRNA | CTD | PMID:31078653 | SLC29A2 | Human | ethanol | affects expression | ISO | Slc29a2 (Mus musculus) | 6480464 | Ethanol affects the expression of SLC29A2 mRNA | CTD | PMID:30319688 | SLC29A2 | Human | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of SLC29A2 mRNA | CTD | PMID:23649840 | SLC29A2 | Human | folic acid | decreases expression | ISO | Slc29a2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SLC29A2 mRNA | CTD | PMID:25629700 | SLC29A2 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of SLC29A2 mRNA | CTD | PMID:23649840 | SLC29A2 | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of SLC29A2 protein | CTD | PMID:37730182 | SLC29A2 | Human | gentamycin | decreases expression | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SLC29A2 mRNA | CTD | PMID:22061828 | SLC29A2 | Human | guanosine | multiple interactions | ISO | Slc29a2 (Mus musculus) | 6480464 | Guanosine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine] | CTD | PMID:11085929 | SLC29A2 | Human | inosine | multiple interactions | ISO | Slc29a2 (Mus musculus) | 6480464 | Inosine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine] | CTD | PMID:11085929 | SLC29A2 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of SLC29A2 mRNA | CTD | PMID:23649840 | SLC29A2 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SLC29A2 mRNA more ... | CTD | PMID:32699268 | SLC29A2 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SLC29A2 mRNA | CTD | PMID:29067470 | SLC29A2 | Human | phenobarbital | affects expression | ISO | Slc29a2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of SLC29A2 mRNA | CTD | PMID:23091169 | SLC29A2 | Human | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of SLC29A2 mRNA | CTD | PMID:29955902 | SLC29A2 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of SLC29A2 mRNA | CTD | PMID:25351596 | SLC29A2 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of SLC29A2 mRNA | CTD | PMID:31533062 | SLC29A2 | Human | tetrachloromethane | increases expression | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of SLC29A2 mRNA | CTD | PMID:31150632 | SLC29A2 | Human | thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of SLC29A2 mRNA | CTD | PMID:27188386 | SLC29A2 | Human | thioacetamide | increases expression | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of SLC29A2 mRNA | CTD | PMID:34492290 | SLC29A2 | Human | thymidine | multiple interactions | ISO | Slc29a2 (Mus musculus) | 6480464 | Thymidine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine] | CTD | PMID:11085929 | SLC29A2 | Human | titanium dioxide | multiple interactions | ISO | Slc29a2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC29A2 mRNA | CTD | PMID:29950665 | SLC29A2 | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of SLC29A2 mRNA | CTD | PMID:30510588 | SLC29A2 | Human | uridine | multiple interactions | EXP | | 6480464 | 4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine] more ... | CTD | PMID:10366666 | SLC29A2 | Human | uridine | multiple interactions | ISO | Slc29a2 (Mus musculus) | 6480464 | 2'-deoxyadenosine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine] more ... | CTD | PMID:11085929 | SLC29A2 | Human | uridine | increases uptake | ISO | Slc29a2 (Mus musculus) | 6480464 | SLC29A2 protein results in increased uptake of Uridine | CTD | PMID:11085929 | SLC29A2 | Human | uridine | increases uptake | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | SLC29A2 protein results in increased uptake of Uridine | CTD | PMID:9353301 | SLC29A2 | Human | uridine | increases uptake | EXP | | 6480464 | SLC29A2 protein results in increased uptake of Uridine | CTD | PMID:10366666 and PMID:9396714 | SLC29A2 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SLC29A2 mRNA | CTD | PMID:25979313 | SLC29A2 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of SLC29A2 gene | CTD | PMID:29154799 | SLC29A2 | Human | vinclozolin | increases expression | ISO | Slc29a2 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of SLC29A2 mRNA | CTD | PMID:23034163 | SLC29A2 | Human | vincristine | decreases expression | EXP | | 6480464 | Vincristine results in decreased expression of SLC29A2 mRNA | CTD | PMID:23649840 | SLC29A2 | Human | zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of SLC29A2 mRNA | CTD | PMID:18356318 | SLC29A2 | Human | zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of SLC29A2 mRNA | CTD | PMID:18356318 | |